Proton and Carbon Ion Radiotherapy Decreased Severe Lymphopenia by Reducing Thoracic Vertebra and Aortic Dose in Non-small Cell Lung Cancer versus Intensity Modulated Radiotherapy.
16/01/2023
/
Publications
Published in the Red Journal, this study reported lymphopenia differences between IMRT and proton/carbon ion (PCIRT) for NSCLC. With data of 343 patients, this...
Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone.
16/01/2023
/
Publications
This study reported outcomes of 19 patients with locoregional recurrent breast cancer treated with PT. All patients had mastectomy without prior RT. Seventeen...
Early Toxicity and Patient-Reported Cosmetic Outcomes in Patients Treated With Adjuvant Proton-Based Radiotherapy After Breast-Conserving Surgery.
16/01/2023
/
Publications
This study reported early toxicity and cosmetic outcomes of 21 patients treated with breast-conserving surgery and adjuvant PBT. Grade 2 and 3 dermatitis...
Advances in Radiation Oncology for Pancreatic Cancer: An Updated Review.
16/01/2023
/
Publications
This review examined studies published in the last 10 years about the advancement of radiotherapy in the treatment of locally advanced pancreatic cancer...
Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma.
16/01/2023
/
Publications
Published by the group from National Cancer Center, Korea, this study reported clinical outcomes of 47 patients with intrahepatic cholangiocarcinoma (IHCC)...
Pattern of Radiotherapy Treatment in Low-Risk, Intermediate-Risk, and High-Risk Prostate Cancer Patients: Analysis of National Cancer Database.
16/01/2023
/
Publications
/
IMRT
With the data from the National Cancer Database, this study investigated the utilization pattern and outcomes of IMRT, brachytherapy (BT), PT and SBRT for...
Particle Therapy in Adult Patients with Pelvic Ewing Sarcoma-Tumor and Treatment Characteristics and Early Clinical Outcomes.
16/01/2023
/
Publications
This study reported early outcomes of 21 adult pelvic Ewing sarcoma treated with PT (n=18 primary disease) to a total dose of 45-60 GyRBE and with carbon ion (n...
ConformalFLASH® from model to delivery
31/05/2021
/
Webinar
/
FLASH Therapy
What are the advantages of FLASH therapy? Where do we stand in FLASH therapy treatment planning? Watch this webinar to understand the latest developments in the...
Cost-effectiveness of proton radiotherapy versus photon radiotherapy for non-small cell lung cancer patients: Exploring the model-based approach.
16/01/2023
/
Publications
/
Model-based approach
Published in the Green Journal, this study compared costs and QALYs of three treatment strategies for patients with stage III NSCLC including 1. photon...
New Uptime Tool for IBA Customers
20/01/1998
/
Webinar
Discover the new IBA Proton Therapy Uptime Tool!
We have prepared a training video to demonstrate the new tool’s features:
• Login to the tool
• ...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.